New shot could ease painful skin condition
NCT ID NCT06411379
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a drug called sonelokimab in 418 adults with moderate to severe hidradenitis suppurativa, a skin condition that causes painful lumps and abscesses. Participants received either the drug or a placebo injection for 16 weeks. The goal was to see if sonelokimab reduces the number of inflamed lumps and draining tunnels by at least 75%.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sonelokimab (a drug injected under the skin)
What this could lead to
If it works, this could provide a new treatment option for people with moderate to severe hidradenitis suppurativa, reducing painful lumps and abscesses.
What could go wrong
This is a completed Phase 3 trial, but results are not yet public. The drug may not work better than placebo, and side effects are possible. It is not a cure, and ongoing treatment may be needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical SIte
Brest, 29200, France
-
Clinical Site
Birmingham, Alabama, 35244, United States
-
Clinical Site
North Little Rock, Arkansas, 72117, United States
-
Clinical Site
Fountain Valley, California, 92708, United States
-
Clinical Site
Santa Monica, California, 90404, United States
-
Clinical Site
Aventura, Florida, 33180, United States
-
Clinical Site
Hialeah, Florida, 33012, United States
-
Clinical Site
Miami, Florida, 33136, United States
-
Clinical Site
Ocala, Florida, 34470, United States
-
Clinical Site
Tampa, Florida, 33613, United States
-
Clinical Site
Skokie, Illinois, 60077, United States
-
Clinical Site
Plainfield, Indiana, 46168, United States
-
Clinical Site
Murray, Kentucky, 42071, United States
-
Clinical Site
Baton Rouge, Louisiana, 70809, United States
-
Clinical Site
Baltimore, Maryland, 21287, United States
-
Clinical Site
Ann Arbor, Michigan, 48109-5314, United States
-
Clinical Site
Canton, Michigan, 48187, United States
-
Clinical Site
Clarkston, Michigan, 48346, United States
-
Clinical Site
Waterford, Michigan, 48328, United States
-
Clinical Site
New Brighton, Minnesota, 55112, United States
-
Clinical Site
Omaha, Nebraska, 68144, United States
-
Clinical Site
Las Vegas, Nevada, 89145, United States
-
Clinical Site
New York, New York, 10003, United States
-
Clinical Site
Fargo, North Dakota, 58103, United States
-
Clinical Site
Columbus, Ohio, 43213, United States
-
Clinical Site
Murfreesboro, Tennessee, 37130, United States
-
Clinical Site
Dallas, Texas, 75390-8565, United States
-
Clinical Site
Plano, Texas, 75025, United States
-
Clinical Site
San Antonio, Texas, 78213, United States
-
Clinical Site
Morgantown, West Virginia, 26505, United States
-
Clinical Site
Milwaukee, Wisconsin, 53226, United States
-
Clinical Site
Ghent, 9000, Belgium
-
Clinical Site
Leuven, 3000, Belgium
-
Clinical Site
Liège, 4000, Belgium
-
Clinical Site
Woluwe-Saint-Lambert, 1200, Belgium
-
Clinical Site
Sofia, 1431, Bulgaria
-
Clinical Site
Sofia, 1463, Bulgaria
-
Clinical Site
Sofia, 1510, Bulgaria
-
Clinical Site
Sofia, 1606, Bulgaria
-
Clinical Site
Stara Zagora, 6003, Bulgaria
-
Clinical Site
Calgary, Alberta, T3E 0B2, Canada
-
Clinical Site
Edmonton, Alberta, T6G 1C3, Canada
-
Clinical Site
Guelph, Ontario, N1L 0B7, Canada
-
Clinical Site
Peterborough, Ontario, K9J 5K2, Canada
-
Clinical Site
Richmond Hill, Ontario, L4B 1A5, Canada
-
Clinical Site
Toronto, Ontario, M4E 1R7, Canada
-
Clinical Site
Windsor, Ontario, N8W 1E6, Canada
-
Clinical Site
Saskatoon, Saskatchewan, S7K 2C1, Canada
-
Clinical Site
Ostrava, 708 52, Czechia
-
Clinical Site
Prague, 110 00, Czechia
-
Clinical Site
Prague, 15006, Czechia
-
Clinical Site
Antony, 92160, France
-
Clinical Site
Besançon, 25030, France
-
Clinical Site
Dijon, 21000, France
-
Clinical Site
Le Mans, 72037, France
-
Clinical Site
Lyon, 69003, France
-
Clinical Site
Montpellier, 34295, France
-
Clinical Site
Rouen, 76031, France
-
Clinical Site
Saint-Mandé, 94160, France
-
Clinical Site
Saint-Priest-en-Jarez, 42270, France
-
Clinical Site
Toulouse, 31400, France
-
Clinical Site
Augsburg, 86179, Germany
-
Clinical Site
Bad Bentheim, 48455, Germany
-
Clinical Site
Berlin, 10117, Germany
-
Clinical Site
Bielefeld, 33647, Germany
-
Clinical Site
Bochum, 44791, Germany
-
Clinical Site
Bramsche, 49565, Germany
-
Clinical Site
Darmstadt, 64283, Germany
-
Clinical Site
Dresden, 01307, Germany
-
Clinical Site
Gera, 07548, Germany
-
Clinical Site
Hamburg, 20246, Germany
-
Clinical Site
Kiel, 24105, Germany
-
Clinical Site
Lübeck, 23538, Germany
-
Clinical Site
Würzburg, 97080, Germany
-
Clinical Site
Dublin, D04 T6F4, Ireland
-
Clinical Site
Rotterdam, 3015 GD, Netherlands
-
Clinical Site
Chorzów, 41-500, Poland
-
Clinical Site
Katowice, 40-611, Poland
-
Clinical Site
Kielce, 25-316, Poland
-
Clinical Site
Olsztyn, 10-229, Poland
-
Clinical Site
Poznan, 61-731, Poland
-
Clinical Site
Szczecin, 70-332, Poland
-
Clinical Site
Warsaw, 02-953, Poland
-
Clinical Site
Wroclaw, 50566, Poland
-
Clinical Site
Trnava, 91702, Slovakia
-
Clinical Site
Alcorcón, 28922, Spain
-
Clinical Site
Alicante, 03010, Spain
-
Clinical Site
Badalona, 08916, Spain
-
Clinical Site
Barcelona, 08003, Spain
-
Clinical Site
Barcelona, 08036, Spain
-
Clinical Site
Barcelona, 08041, Spain
-
Clinical Site
Cadiz, 11009, Spain
-
Clinical Site
Córdoba, 14004, Spain
-
Clinical Site
Granada, 18012, Spain
-
Clinical Site
Granada, 18014, Spain
-
Clinical Site
Granollers, 08402, Spain
-
Clinical Site
Madrid, 28006, Spain
-
Clinical Site
Madrid, 28007, Spain
-
Clinical Site
Madrid, 28041, Spain
-
Clinical Site
Madrid, 28046, Spain
-
Clinical Site
Manises, 46940, Spain
-
Clinical Site
Málaga, 29010, Spain
-
Clinical Site
Santiago de Compostela, 15706, Spain
-
Clinical Site
Seville, 41009, Spain
-
Clinical Site
Valencia, 46014, Spain
-
Clinical Site
Valencia, 46026, Spain